Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Orito

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Journal of Gastroenterology and Hepatology|November 1, 1995
Cystic lymphangioma of the gall-bladder: a case reportK Ohba, F Sugauchi, E Orito, et al.
Journal of Medical Virology|December 1, 1994
Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis CE Orito, M Mizokami, T Nakano, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|January 1, 1992
[A case of HBsAg positive liver cirrhosis who died after withdrawal of steroid]K Kumada, M Mizokami, E Orito, et al.
Journal of Hepatology|December 1, 1995
Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremiaT Tanaka, J Y Lau, M Mizokami, et al.
Gut|December 1, 1996
Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypesE Orito, M Mizokami, T Tanaka, et al.
Journal of Gastroenterology and Hepatology|January 1, 1997
Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatmentE Orito, M Mizokami, K Suzuki, et al.
Journal of Gastroenterology|April 1, 1995
Genotype distribution in Nagoya and new genotype (genotype 3a) in Japanese patients with hepatitis C virusT Ohno, M Mizokami, M Yamauchi, et al.
Journal of Clinical Microbiology|January 1, 1997
New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6aO Ohno, M Mizokami, R R Wu, et al.
Journal of Medical Virology|June 1, 1995
Loss of serum HCV RNA at week 4 of interferon-alpha therapy is associated with more favorable long-term response in patients with chronic hepatitis CE Orito, M Mizokami, K Suzuki, et al.
Journal of Medical Virology|March 24, 1999
Amino acid substitutions in NS5A region of GB virus C and response to interferon therapyT Kato, M Mizokami, E Orito, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Journal of Gastroenterology and Hepatology|November 1, 1995
Cystic lymphangioma of the gall-bladder: a case reportK Ohba, F Sugauchi, E Orito, et al.
Journal of Medical Virology|December 1, 1994
Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis CE Orito, M Mizokami, T Nakano, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|January 1, 1992
[A case of HBsAg positive liver cirrhosis who died after withdrawal of steroid]K Kumada, M Mizokami, E Orito, et al.
Journal of Hepatology|December 1, 1995
Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremiaT Tanaka, J Y Lau, M Mizokami, et al.
Gut|December 1, 1996
Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypesE Orito, M Mizokami, T Tanaka, et al.
Journal of Gastroenterology and Hepatology|January 1, 1997
Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatmentE Orito, M Mizokami, K Suzuki, et al.
Journal of Gastroenterology|April 1, 1995
Genotype distribution in Nagoya and new genotype (genotype 3a) in Japanese patients with hepatitis C virusT Ohno, M Mizokami, M Yamauchi, et al.
Journal of Clinical Microbiology|January 1, 1997
New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6aO Ohno, M Mizokami, R R Wu, et al.
Journal of Medical Virology|June 1, 1995
Loss of serum HCV RNA at week 4 of interferon-alpha therapy is associated with more favorable long-term response in patients with chronic hepatitis CE Orito, M Mizokami, K Suzuki, et al.
Journal of Medical Virology|March 24, 1999
Amino acid substitutions in NS5A region of GB virus C and response to interferon therapyT Kato, M Mizokami, E Orito, et al.
Pageof 8